Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Anti-atherogenic properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy.

Hussein O, Izikson L, Bathish Y, Dabur E, Hanna A, Zidan J.

J Psychopharmacol. 2015 Dec;29(12):1262-70. doi: 10.1177/0269881115598320. Epub 2015 Aug 7.

PMID:
26253619
2.

Clinical stage of Merkel cell carcinoma and survival are not associated with Breslow thickness of biopsied tumor.

Izikson L, Helm T, Sroa N, Zeitouni NC.

Dermatol Surg. 2012 Aug;38(8):1351-6. doi: 10.1111/j.1524-4725.2012.02398.x. Epub 2012 Mar 27.

PMID:
22455371
3.

All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease.

St Denis TG, Dai T, Izikson L, Astrakas C, Anderson RR, Hamblin MR, Tegos GP.

Virulence. 2011 Nov-Dec;2(6):509-20. doi: 10.4161/viru.2.6.17889. Epub 2011 Nov 1. Review.

4.

Surgical scar remodelling after photodynamic therapy using aminolaevulinic acid or its methylester: a retrospective, blinded study of patients with field cancerization.

Sakamoto FH, Izikson L, Tannous Z, Zurakowski D, Anderson RR.

Br J Dermatol. 2012 Feb;166(2):413-6. doi: 10.1111/j.1365-2133.2011.10576.x. Epub 2011 Nov 17.

PMID:
21848691
5.

A prospective, randomized controlled trial on the efficacy of fractional photothermolysis on scar remodeling.

Lin JY, Warger WC, Izikson L, Anderson RR, Tannous Z.

Lasers Surg Med. 2011 Apr;43(4):265-72. doi: 10.1002/lsm.21061. No abstract available.

PMID:
21500220
6.

Merkel cell carcinoma associated with HIV: review of 14 patients.

Izikson L, Nornhold E, Iyer JG, Nghiem P, Zeitouni NC.

AIDS. 2011 Jan 2;25(1):119-21. doi: 10.1097/QAD.0b013e328340a19c. No abstract available.

7.

Prevalence of underdiagnosed aggressive non-melanoma skin cancers treated with Mohs micrographic surgery: analysis of 513 cases.

Izikson L, Seyler M, Zeitouni NC.

Dermatol Surg. 2010 Nov;36(11):1769-72. No abstract available.

PMID:
20979340
8.

Noninvasive extramammary Paget's disease treated with photodynamic therapy: case series from the Roswell Park Cancer Institute.

Housel JP, Izikson L, Zeitouni NC.

Dermatol Surg. 2010 Nov;36(11):1718-24. doi: 10.1111/j.1524-4725.2010.01734.x. Epub 2010 Sep 17.

PMID:
20849546
9.

Safety and effectiveness of black tattoo clearance in a pig model after a single treatment with a novel 758 nm 500 picosecond laser: a pilot study.

Izikson L, Farinelli W, Sakamoto F, Tannous Z, Anderson RR.

Lasers Surg Med. 2010 Sep;42(7):640-6. doi: 10.1002/lsm.20942.

PMID:
20740618
10.

Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions.

Hawryluk EB, Izikson L, English JC 3rd.

Am J Clin Dermatol. 2010;11(3):171-81. doi: 10.2165/11530080-000000000-00000. Review.

PMID:
20184390
11.

Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients.

Izikson L, Nelson JS, Anderson RR.

Lasers Surg Med. 2009 Aug;41(6):427-32. doi: 10.1002/lsm.20793.

12.

Cutaneous sarcoidosis associated with cosmetic fillers.

Izikson L.

J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1455-6. doi: 10.1111/j.1468-3083.2009.03249.x. Epub 2009 Apr 2. No abstract available.

PMID:
19368615
13.

Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.

Izikson L, Anderson RR.

Dermatol Surg. 2009 Mar;35(3):527-9. doi: 10.1111/j.1524-4725.2009.01082.x. Epub 2009 Feb 22. No abstract available.

PMID:
19250303
14.

Treatment endpoints for resistant port wine stains with a 755 nm laser.

Izikson L, Anderson RR.

J Cosmet Laser Ther. 2009 Mar;11(1):52-5. doi: 10.1080/14764170802524452.

PMID:
19012069
15.

Treatment of port wine stains with pulsed dye laser in patients with systemic lupus erythematosus: practical considerations and complications.

Izikson L, Avram M, Tannous Z.

J Cosmet Laser Ther. 2008 Dec;10(4):223-5. doi: 10.1080/14764170802307965.

PMID:
18830867
16.

Laser photorejuvenation of Asian and ethnic skin.

Izikson L.

J Cosmet Laser Ther. 2008 Sep;10(3):161-6. doi: 10.1080/14764170802308427. Review.

PMID:
18788034
17.

Resolution of blue minocycline pigmentation of the face after fractional photothermolysis.

Izikson L, Anderson RR.

Lasers Surg Med. 2008 Aug;40(6):399-401. doi: 10.1002/lsm.20648. No abstract available.

PMID:
18649380
18.

Transient immunoreactivity after laser tattoo removal: report of two cases.

Izikson L, Avram M, Anderson RR.

Lasers Surg Med. 2008 Apr;40(4):231-2. doi: 10.1002/lsm.20618.

PMID:
18412226
19.

Noninfectious granulomatous diseases: an update.

Izikson L, English JC.

Adv Dermatol. 2006;22:31-53. Review. No abstract available.

PMID:
17249294
20.

The flushing patient: differential diagnosis, workup, and treatment.

Izikson L, English JC 3rd, Zirwas MJ.

J Am Acad Dermatol. 2006 Aug;55(2):193-208. Review.

PMID:
16844500
21.

The ICOS molecule plays a crucial role in the development of mucosal tolerance.

Miyamoto K, Kingsley CI, Zhang X, Jabs C, Izikson L, Sobel RA, Weiner HL, Kuchroo VK, Sharpe AH.

J Immunol. 2005 Dec 1;175(11):7341-7.

22.

Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors.

Izikson L, Bhan A, Zembowicz A.

Am J Dermatopathol. 2005 Apr;27(2):91-5.

PMID:
15798431
23.

Combined basal cell carcinoma and Langerhans cell histiocytosis of the scrotum in a patient with occupational exposure to coal tar and dust.

Izikson L, Vanderpool J, Brodsky G, Mihm MC Jr, Zembowicz A.

Int J Dermatol. 2004 Sep;43(9):678-80. No abstract available.

PMID:
15357751
24.

IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.

Int Immunol. 2004 Feb;16(2):249-56.

PMID:
14734610
25.

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.

26.

Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases.

Izikson L, Sober AJ, Mihm MC Jr, Zembowicz A.

Arch Dermatol. 2002 Dec;138(12):1562-6.

PMID:
12472343
27.

Targeting monocyte recruitment in CNS autoimmune disease.

Izikson L, Klein RS, Luster AD, Weiner HL.

Clin Immunol. 2002 May;103(2):125-31. Review.

PMID:
12027417
28.

Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.

Zhang X, Izikson L, Liu L, Weiner HL.

J Immunol. 2001 Oct 15;167(8):4245-53.

29.

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.

Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, Ansorge S, Brocke S.

J Immunol. 2001 Feb 1;166(3):2041-8.

30.

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD.

J Exp Med. 2000 Oct 2;192(7):1075-80.

31.

Dipeptidyl peptidase IV in inflammatory CNS disease.

Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, Ansorge S, Brocke S.

Adv Exp Med Biol. 2000;477:145-53.

PMID:
10849741
32.

Differential display analysis of murine encephalitogenic mRNA.

Jeong MC, Izikson L, Uccelli A, Brocke S, Oksenberg JR.

Int Immunol. 1998 Dec;10(12):1819-23.

PMID:
9885902
33.

[Results of treatment in cases with bilateral retinoblastoma (author's transl)].

Chwatowa AW, Weinstein ES, Dimitrowskaja IP, Izikson LJ, Burdjanskaja EI, Sorokina MN, Timakowa WI.

Klin Monbl Augenheilkd. 1980 May;176(5):758-63. German.

PMID:
7442047

Supplemental Content

Loading ...
Support Center